Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term immunological responses to venom immunotherapy in hymenoptera venom allergy with or without indolent systemic mastocytosis
NL-OMON48343Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2019
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of wasp venom extract in insect sting allergy (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Change in proliferating Th2-cell fraction within allergen-specific CD4+ T cells at 7 months. Started Mar 2019; status: recruiting.
02
Drugs
wasp venom extract
03
Conditions
insect sting allergy
Beyond the preview
Go deeper on NL-OMON48343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48343.